Possibilities and problems of immunologic intervention in cancer.

No abstract is available for this paper.

• Publication year

  1972

• Venue

  New England Journal of Medicine

• Publication date

  1972-08-31

• Fields of study

  Medicine

• Identifiers
  DOI 10.1056/NEJM197208312870905PMID 4558044
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Demonstration of an antigen common to several varieties of neoplasia.

  1971cited by this paper
• Serum factors in tumor‐free patients cancelling the blocking of cell‐mediated tumor immunity

  1971cited by this paper
• Demonstration of cell‐mediated immunity to human neoplasms of various histological types

  1971cited by this paper
• Immunotherapy for the Patient with Cancer

  1971cited by this paper
• "Unblocking" serum activity in vitro in the polyoma system may correlate with antitumour effects of antiserum in vivo.

  1971cited by this paper
• Serum-mediated Immunological Non-reactivity between Histoincompatible Cells in Tetraparental Mice

  1971cited by this paper
• Redistribution and pinocytosis of lymphocyte surface immunoglobulin molecules induced by anti-immunoglobulin antibody.

  1971cited by this paper
• Inhibition of migration of human autogenous and allogeneic leukocytes by extracts of patients' cancers.

  1971cited by this paper
• Rendering macrophages specifically cytotoxic by a factor released from immune lymphoid cells.

  1971cited by this paper
• Specificity of Allogeneic Cell Recognition by Human Lymphocytes in vitro

  1971cited by this paper
• Phytohemagglutinin Unresponsiveness in Mouse Spleen Cells Induced by Methylcholanthrene Sarcomas

  1971cited by this paper
• A factor in maternal plasma during pregnancy that suppresses the reactivity of mixed leukocyte cultures.

  1971cited by this paper
• Possible Explanation for Loss of Detectable Antibody in Patients with Disseminated Malignant Melanoma

  1971cited by this paper
• Enhanced growth of primary moloney virus‐induced sarcomas in mice

  1971cited by this paper
• Blocking of cell‐mediated tumor immunity by sera from patients with growing neoplasms

  1971cited by this paper
• Studies concerning the regional lymph node in cancer. I. Initiation of immunity

  1971cited by this paper
• Circulating cancer cells: Pre‐and post‐chemotherapy observations

  1971cited by this paper
• Immunotherapy of cancer.

  1971cited by this paper
• Delayed cutaneous hypersensitivity reactions to membrane extracts of human tumour cells.

  1971cited by this paper
• Nephrotic syndrome in malignant disease of non-renal origin.

  1971cited by this paper
• The lymphocyte and human lung cancers.

  1971cited by this paper
• Immunological tolerance: "forbidden clones" allowed in tetraparental mice.

  1971cited by this paper
• In Vitro Responses of Lymphocytes from Cancer-Bearing Patients to Autochthonous Tumor Tissues 1

  1971cited by this paper
• In vitro desensitization of sensitized murine lymphocytes by a serum factor (soluble antigen?).

  1971cited by this paper
• Immunotherapy of Cancer: Immunospecific Rejection of Tumors in Recipients of Neuraminidase-Treated Tumor Cells Plus BCG

  1971cited by this paper
• Immunological studies with human neoplasms.

  1971cited by this paper
• Phytohemagglutinin (PHA)‐induced transformation of lymphocytes from patients with cancer

  1971cited by this paper
• Antibody-mediated suppression of the immune response in vitro. 3. Low zone tolerance in vitro.

  1971cited by this paper
• Enhanced immunogenicity of chemically-coated syngeneic tumor cells.

  1971cited by this paper
• ISOLATION OF A TUMOR FACTOR RESPONSIBLE FOR ANGIOGENESIS

  1971cited by this paper
• Blocking effect of serum from tumor-bearing animals on macrophage migration inhibition with tumor antigens.

  1971cited by this paper
• Neonatally Induced Allograft Tolerance may be mediated by Serum-borne Factors

  1971cited by this paper
• The role of blocking antibodies in immunological enhancement.

  1971cited by this paper
• Immunotherapy of Cancer: Regression of Tumors after Intralesional Injection of Living Mycobacterium bovis

  1971cited by this paper
• Suggestive evidence that the "blocking antibodies" of tumor-bearing individuals may be antigen--antibody complexes.

  1971cited by this paper
• Cellular immunity to nephroblastoma

  1971cited by this paper
• Cutaneous hypersensitivity reactions to autologous extracts of malignant melanoma cells.

  1970cited by this paper
• Studies of an inhibitor of DNA synthesis and a nonspecific mitogen elaborated by human lymphoblasts.

  1970cited by this paper
• Growth stimulation of tissue culture cells derived from patients with neuroblastoma.

  1970cited by this paper
• Cell‐mediated immunity against antigens common to human colonic carcinomas and fetal gut Epithelium

  1970cited by this paper
• CELLULAR RECOGNITION BY MOUSE LYMPHOCYTES IN VITRO

  1970cited by this paper
• Colony inhibition of fibroblasts from chimeric dogs mediated by the dogs' own lymphocytes and specifically abrogated by their serum.

  1970cited by this paper
• The role of immunoblasts in host resistance and immunotherapy of primary sarcomata.

  1970cited by this paper
• QUANTITATIVE STUDIES ON THE MIXED LYMPHOCYTE INTERACTION IN RATS

  1970cited by this paper
• Neuraminidase Activity in HeLa Cells: Effect of Hydrocortisone

  1970cited by this paper
• Cellular and humoral immune responses to human urinary bladder carcinomas

  1970cited by this paper
• The relationship of delayed hypersensitivity to acquired antituberculous immunity. I. Tuberculin sensitivity and resistance to reinfection in BCG-vaccinated mice.

  1970cited by this paper
• Delayed cutaneous hypersensitivity reactions to autologous extracts of Burkitt-lymphoma cells.

  1970cited by this paper
• Cooperation of Immune Lymphoid Cells with Macrophages in Tumour Immunity

  1970cited by this paper
• Role of Thymus-derived Lymphocytes in the Secondary Humoral Immune Response in Mice

  1970cited by this paper
• Clinical immunologic responsiveness in malignant disease. I. Delayed hypersensitivity reaction and the effect of cytotoxic drugs

  1970cited by this paper
• Colony inhibition studies on blocking and non‐blocking serum effects on cellular immunity to moloney sarcomas

  1970cited by this paper
• The Nephrotic Syndrome: A Prodrome to Lymphoma

  1970cited by this paper
• Nephrotic syndrome: a prodrome to lymphoma.

  1970cited by this paper
• Immune response to urinary bladder tumours in man

  1970cited by this paper
• Tumor Immunity Produced by the Intradermal Inoculation of Living Tumor Cells and Living Mycobacterium bovis (Strain BCG)

  1970cited by this paper
• Skin-reactive soluble antigen from intestinal cancer-cell-membranes and relationship to carcinoembryonic antigens.

  1970cited by this paper
• Active Immunotherapy with Corynebacterium parvum and Chemotherapy in Murine Fibrosarcomas

  1970cited by this paper
• In vitro lymphocyte stimulation by a soluble antigen from malignant melanoma.

  1970cited by this paper
• Indication of tumour specific cell-bound immunological reactivity and depressed general reactivity in a pair of twins.

  1970cited by this paper
• Sinus histiocytosis and mammary carcinoma. Study of 366 radical mastectomies and an historical review

  1970cited by this paper
• Five‐year cancer cure: Relation to total amount of peripheral lymphocytes and neutrophils

  1970cited by this paper
• Microcytotoxicity Test: Detection in Sarcoma Patients of Antibody Cytotoxic to Human Sarcoma Cells

  1970cited by this paper
• Serum alpha‐feto‐protein and primary cancer of the liver in man

  1970cited by this paper
• Studies on cellular immunity to human neuroblastoma cells

  1970cited by this paper
• The relationship of delayed hypersensitivity to acquired antituberculous immunity. II. Effect of adjuvant on the allergenicity and immunogenicity of heat-killed tubercle bacilli.

  1970cited by this paper
• Impaired immunologic reactivity and recurrence following cancer surgery

  1970cited by this paper
• A collaborative study for the evaluation of a serologic test for primary liver cancer

  1970cited by this paper
• Immunological enhancement as studied by cell culture techniques.

  1970cited by this paper
• Hypersensitivity reactions at tumor sites.

  1969cited by this paper
• Immunotherapy and chemotherapy of Moloney sarcoma virus-induced tumors in mice.

  1969cited by this paper
• Active immunotherapy for acute lymphoblastic leukaemia.

  1969cited by this paper
• Active immunotherapy of L1210 leukaemia applied after the graft of tumour cells.

  1969cited by this paper
• Stimulation of Lymphocytes by Autologous Leukaemic Cells in Acute Leukaemia

  1969cited by this paper
• Effect of autologous tumor extracts on cultured human peripheral blood lymphocytes

  1969cited by this paper
• Tumor‐specific transplantation immunity after cryosurgery

  1969cited by this paper
• Tumour-specific Antibodies in Human Malignant Melanoma and their Relationship to the Extent of the Disease

  1969cited by this paper
• Cellular immunity against tumor antigens.

  1969cited by this paper
• The radioimmunoassay of circulating carcinoembryonic antigen of the human digestive system.

  1969cited by this paper
• The cellular immune response to primary sarcomata in rats II. Abnormal responses of nodes draining the tumour

  1969cited by this paper
• Serum-mediated protection of neoplastic cells from inhibition by lymphocytes immune to their tumor-specific antigens.

  1969cited by this paper
• The presence of delayed hypersensitivity reactions in patients toward cellular extracts of their malignant tumors 1. The role of tissue antigen, nonspecific reactions of nuclear material, and bacterial antigen as a cause for this phenomenon

  1969cited by this paper
• Immunology of cancer with special Reference to Tumor Immunity in the Primary Autochthonous Host

  1969cited by this paper
• [Immune reaction and facilitating antibodies in animals tolerating homografts].

  1968cited by this paper
• Tumor-specific immune mechanisms.

  1968cited by this paper
• Tumor-specific immune mechanisms.

  1968cited by this paper
• Tumors of the skin. X. Immunotherapy of cutaneous and mucosal neoplasms.

  1968cited by this paper
• Possible host resistance in carcinoma of the breast: a histological study.

  1968cited by this paper
• Tumor-specific immune mechanisms.

  1968cited by this paper
• ANTIGENIC MODULATION

  1968cited by this paper
• Immune response in mice with plasma-cell tumor (X5563) assayed by agar plaque technique.

  1968cited by this paper
• Demonstration of cell-bound and humoral immunity against neuroblastoma cells.

  1968cited by this paper
• QUANTITATIVE STUDIES ON THE MIXED LYMPHOCYTE INTERACTION IN RATS

  1967cited by this paper
• Stromal reaction around tumor and metastasis and prognosis after curative gastrectomy for carcinoma of the stomach

  1967cited by this paper
• Prognostic significance of cancer cells in the circulating blood. A ten year evaluation.

  1967cited by this paper
• Inhancement activity of mouse immunoglobulin classes.

  1967cited by this paper
• Membrane immunofluorescence reactions of Burkitt lymphoma cells from biopsy specimens and tissue cultures.

  1967cited by this paper
• Reactivity of human lymphocytes against autochthonous and allogeneic normal and tumor cells in vitro.

  1967cited by this paper
• Immunological Aspects of Viral Oncolysis

  1967cited by this paper
• Effect of Nucleic Acids from Immune Lymphocytes on Rat Sarcomata

  1967cited by this paper

• in the Treatment of Leukemia and Lymphoma

  2016cites this paper
• T ransfer Factor as a Probe of the Immune Defect in Lepromatous Leprosy

  2012cites this paper
• The Structure of Mononuclear Phagocytes Differentiating In Vivo of the Effect of

  2007cites this paper
• The Influence of on the Course of Nonspecific lmmunotherapy Murine Melanoma

  2006cites this paper
• DEVELOPMENTS IN VETERINARY SCIENCE NEOPLASIA-VWHAT ARE THE PROSPECTS OF IMMUNOLOGICAL INTERVENTION?

  2006influential citation
• In Vivo and in Vitro Evaluation of Immune Response of Hamsters to Immunization and Transplants of Autochthonous Reticulum Cell Sarcoma 1

  2006influential citation
• Immunochemotherapy with 5'-deoxy-5-fluorouridine and streptococcal preparation OK-432 against AH 66 ascites hepatoma in rats

  1995cites this paper
• Cancer and the immune system.

  1994cites this paper
• Tumoren des Urogenitaltraktes

  1992cites this paper
• Clinico‐pathological Evaluation of Repeated Intratumoral Injection Therapy of OK‐432 for Inoperable Gastric Carcinomas

  1991cites this paper
• Is cancer a macrophage-mediated autoaggressive disease?

  1987cites this paper
• Chemical of Current Interest-Benzene

  1987cites this paper
• Macrophage migration inhibition factor test in breast tumors.

  1986cites this paper
• Modulation of immunity by macrophages

  1985cites this paper
• Post operative stimulation of cell mediated immunity

  1985cites this paper
• POSTOPERATIVE ANTICANCER IMMUNOCHEMOTHERAPY FOR COLORECTAL CARCINOMA

  1984cites this paper
• Efficacy of streptococcal preparation OK-432 for gastric cancer patients—comparison between intradermal and intramuscular injection

  1984cites this paper
• Comparison of immunological responses and survival periods in cancer patients treated with intradermal and intramuscular injection of the streptococcal preparation OK-432.

  1984cites this paper
• Utilization of monoclonal antibodies in the treatment of leukemia and lymphoma.

  1982cites this paper
• Regional immunotherapy has a detrimental effect on the response to combined irradiation and chemotherapy in locally advanced non-small cell bronchogenic carcinoma

  1981cites this paper
• Serotherapy of acute lymphoblastic leukemia with monoclonal antibody.

  1981cites this paper
• Indomethacin‐sensitive suppressor cells regulate the cell‐mediated cytotoxic response to SV 40‐induced tumor‐associated antigens in mice

  1980cites this paper
• Wert der prophylaktischen Gabe von Immunglobulin bei aggressiver Chemotherapie

  1980cites this paper
• Clinical studies on cell‐mediated immunity in patients with malignant disease I. Effect of immunotherapy with OK‐432 on lymphocyte subpopulation and phytomitogen responsiveness in vitro

  1980cites this paper
• Clinical studies on cell-mediated immunity in patients with malignant disease

  1980cites this paper
• Regulatory action of THF on T-cell reactivity to mitogens.

  1980cites this paper
• Factors influencing localization of labeled antibodies in tumors.

  1980cites this paper
• Lymphocyte functions in cancer.

  1979cites this paper
• Immunotherapy models in experimental animals.

  1979cites this paper
• Influence of diet upon the neoplastic diseases of the rodent.

  1979cites this paper
• Clinical uses of microorganisms and their products.

  1979cites this paper
• Prevention of sarcoma in guinea pigs by transfer factor

  1979cites this paper
• The in vitro effect of a calf thymus extract on the peripheral blood lymphocytes of sixty-six melanoma patients.

  1979cites this paper
• Patterns of lymphoid infiltrate in the canine cutaneous histiocytoma.

  1979cites this paper
• Effect of fetal thymic extract on maturation of precursor lymphocytes from cancer patients with various stages.

  1979cites this paper
• Ovarian cancer: a solid tumor with evidence of normal cellular immune function but abnormal B cell function.

  1979cites this paper
• Effects of acetaminophen on normal human peripheral blood lymphocytes: enhancement of mitogen- and antigen-stimulated incorporation of tritiated thymidine.

  1979cites this paper
• EFFECT OF CYCLOPHOSPHAMIDE AND METHYLPREDNISOLONE ON IN VITRO CELLULAR IMMUNE RESPONSE TO ALLOGENEIC TUMOR CELLS CORRELATION WITH IN VIVO REJECTION

  1978cites this paper
• Regression of a T-cell lymphoma after administration of antithymocyte globulin.

  1978cites this paper
• Immunotherapy for cancer.

  1978cites this paper
• Suppressor cell activity in cancer patients: a possible role for thymic hormones.

  1978cites this paper
• Comparison of the effects of single versus multiple agent chemotherapy on lymphocytes assayed by the rosette technique

  1978cites this paper
• Immunological Aspects of Cancer

  1978cites this paper
• Aging and Involution of the Immunological Apparatus

  1978cites this paper
• Lymphocyte cytotoxicity in the X-irradiation induced rat small bowel adenocarcinoma. II. Presence of cytotoxic lymphocytes in irradiated animals.

  1978cites this paper
• In vitro testing of the immune response

  1978cites this paper
• Adjuvant treatment of colorectal cancer.

  1977cites this paper
• The allogeneic effect on tumor growth. I. Inhibition of a murine plasmacytoma, MOPC 315, by the graft-vs-host reaction.

  1977cites this paper
• The role of ige in the immune response to neoplasia: A review

  1977cites this paper
• [DNA turnover in metastasis-free organs of tumor bearing mice; influence on whole body measurements with 125I-UdR (author's transl)].

  1977cites this paper
• Inhibition of macrophage chemotaxis by neoplastic and other rapidly proliferating cells in vitro.

  1977cites this paper
• Adjuvant treatment with levamisole in cancer: a review of experimental and clinical data.

  1977cites this paper
• Castration effects on tumor specific immunity.

  1977cites this paper
• The influence of nonspecific immunotherapy on the course of Murine Melanoma

  1977cites this paper
• Transfer factor as a probe of the immune defect in lepromatous leprosy.

  1977cites this paper
• Animal models for tumor immunotherapy — A commentary

  1977cites this paper
• Passive immunotherapy of cancer in animals and man.

  1977cites this paper
• Tumor Immunology and Immunotherapy

  1977cites this paper
• Inhibitionof MacrophageChemotaxisby Neoplastic and Other Rapidly ProliferatingCells in Vitro1

  1977cites this paper
• Immunotherapy and human tumor immunology.

  1976cites this paper
• T-cell rosette test in squamous cell carcinoma of the head and neck.

  1976cites this paper
• Immunology for Surgeons

  1976cites this paper
• Feasibility study of active immunotherapy in patients with solid tumors

  1976cites this paper
• Immunological aspects of host resistance to the development and growth of cancer.

  1976cites this paper
• Active immunoprophylaxis and immunotherapy in two mouse lymphoma models.

  1976cites this paper
• Human colonic adenocarcinoma cells

  1976cites this paper
• An immunologic approach to tumor imaging.

  1976cites this paper
• The Role of Cellular Immunity in Neoplasia

  1976cites this paper
• Blocking and unblocking serum factors in neoplasia.

  1976cites this paper
• 9 – Nonspecific Immunoregulation by Macrophages and Their Products

  1976cites this paper
• Immunology of prostatic carcinoma-an overview.

  1976cites this paper
• Neuraminidase immunotherapy: Serum potentiation of lymphocyte cytotoxicity related to immunoglobulin levels

  1976cites this paper
• T-cell rosette test in squamous cell carcinoma of the head and neck.

  1976cites this paper
• Kaposi's sarcoma in an immunosuppressed renal allograft recipient.

  1976cites this paper
• Purification of soluble human melanoma-associated antigens.

  1976cites this paper
• PRECLINICAL APPROACHES IN TUMOR IMMUNOCHEMOTHERAPY

  1976cites this paper
• Immunotherapy of Human Tumours

  1976cites this paper
• Effects of operation on immune response in cancer patients: sequential evaluation of in vitro lymphocyte function.

  1976cites this paper
• BCG immunoprophylaxis of recurrent herpes progenitalis.

  1976cites this paper
• SUPPRESSION OF MIXED LYMPHOCYTE RESPONSE IN MICE BEARING PRIMARY TUMORS INDUCED BY MURINE SARCOMA VIRUS

  1976cites this paper
• TRANSFER FACTOR VERSUS COMBINATION CHEMOTHERAPY: A PRELIMINARY REPORT OF A RANDOMIZED POSTSURGICAL ADJUVANT TREATMENT STUDY IN OSTEOGENIC SARCOMA *

  1976cites this paper
• [Immunostimulation in the treatment of malignant diseases].

  1975cites this paper
• Modifying the immunogenicity of cell membrane antigens. Tumors and transplants.

  1975cites this paper
• Elevated IgA in carcinoma of the nasopharynx

  1975cites this paper
• Neoplasia in kidney transplant recipients.

  1975cites this paper
• Osteogenic sarcoma. Immunologic parameters before and during immunotherapy with tumor-specific transfer factor.

  1975cites this paper
• [Immunopotentiation: aims, ways, results].

  1975cites this paper
• Factor(s) from Ehrlich Ascites Cells Responsible for Delayed Rejection of Skin Allografts in Mice and Its Assay on Lymphocytes in Vitro

  1975cites this paper
• Possible role of nutrients in neoplasia.

  1975cites this paper
• Current concepts of chronic benzene toxicity.

  1975cites this paper
• Autoimmune Diseases of the Skin and Skin Disorders with Diverse Immuno-Pathological Abnormalities

  1975cites this paper
• Multiple primary malignancies in patients with alcoholic liver disease. A report of two cases.

  1975cites this paper
• A relationship between impaired cellular immunity humoral suppression of lymphocyte function and severity of systemic lupus erythematosus.

  1975cites this paper
• Thymosin‐induced increase in E‐rosette‐forming capacity of lymphocytes in patients with malignant neoplasms

  1975cites this paper
• Rationale of combined modality therapy for cancer.

  1974cites this paper
• "Immunostaging" as a guideline to immunotherapy in malignancy.

  1974cites this paper
• Treatment of infectious and neoplastic diseases with transfer factor.

  1974cites this paper
• The structure of mononuclear phagocytes differentiating in vivo. I. Sequential fine and histologic studies of the effect of Bacillus Calmette-Guerin (BCG).

  1974cites this paper
• Generation of non-complement-fixing, blocking factors by lysosomal extract treatment of cytotoxic anti-tumor antibodies.

  1974cites this paper
• Immunologic reduction of bladder cancer recurrence rate.

  1974cites this paper